We are pioneers in the field of mental health with a focus on bipolar affective disorder with digital therapies and our goal is to offer the Mindpax system to everyone who needs it!
Therefore, we have started discussions with the Federal Institute for Drugs and Medical Devices (BfArM) in Germany. We want to take advantage of the reimbursement from German health insurance companies, which contribute to the therapy with medication, medical devices and also digital care.
This is a great opportunity for Mindpax to become a digital therapeutic reimbursed from the public health insurance system. This spring we will be applying for acceptance into a pilot program for novel digital therapeutics (DiGA). Our entire team is now working as hard as possible to be included in the program and to pass all phases successfully so that we can be launched on the German market.
Keep your fingers crossed that we succeed!
